456 related articles for article (PubMed ID: 17286567)
1. Left atrial appendage exclusion and the risk of thromboembolic events following mitral valve surgery.
Almahameed ST; Khan M; Zuzek RW; Juratli N; Belden WA; Asher CR; Novaro GM; Martin DO; Natale A
J Cardiovasc Electrophysiol; 2007 Apr; 18(4):364-6. PubMed ID: 17286567
[TBL] [Abstract][Full Text] [Related]
2. Late incidence and determinants of stroke after aortic and mitral valve replacement.
Ruel M; Masters RG; Rubens FD; Bédard PJ; Pipe AL; Goldstein WG; Hendry PJ; Mesana TG
Ann Thorac Surg; 2004 Jul; 78(1):77-83; discussion 83-4. PubMed ID: 15223407
[TBL] [Abstract][Full Text] [Related]
3. Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement.
Blair KL; Hatton AC; White WD; Smith LR; Lowe JE; Wolfe WG; Young WG; Oldham HN; Douglas JM; Glower DD
Circulation; 1994 Nov; 90(5 Pt 2):II214-9. PubMed ID: 7955256
[TBL] [Abstract][Full Text] [Related]
4. Concurrent prophylactic left atrial appendage exclusion: results from a randomized controlled trial pilot study.
Nagpal AD; Torracca L; Fumero A; Denti P; Cioni M; Alfieri O
Eur J Cardiothorac Surg; 2009 Sep; 36(3):553-7. PubMed ID: 19473853
[TBL] [Abstract][Full Text] [Related]
5. Effect of surgery for atrial fibrillation associated with mitral valve disease.
Fukunaga S; Hori H; Ueda T; Takagi K; Tayama E; Aoyagi S
Ann Thorac Surg; 2008 Oct; 86(4):1212-7. PubMed ID: 18805163
[TBL] [Abstract][Full Text] [Related]
6. Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
Nuñez L; Pinto AG; Larrea JL; Gil Aguado M; Connor FO
Z Kardiol; 1986; 75 Suppl 2():321-5. PubMed ID: 3727711
[No Abstract] [Full Text] [Related]
7. Left atrial appendage exclusion during mitral valve surgery and stroke in atrial fibrillation.
Abrich VA; Narichania AD; Love WT; Lanza LA; Shen WK; Sorajja D
J Interv Card Electrophysiol; 2018 Dec; 53(3):285-292. PubMed ID: 30267182
[TBL] [Abstract][Full Text] [Related]
8. Mitral mechanical replacement in young rheumatic women: analysis of long-term survival, valve-related complications, and pregnancy outcomes over a 3707-patient-year follow-up.
De Santo LS; Romano G; Della Corte A; Tizzano F; Petraio A; Amarelli C; De Feo M; Dialetto G; Scardone M; Cotrufo M
J Thorac Cardiovasc Surg; 2005 Jul; 130(1):13-9. PubMed ID: 15999035
[TBL] [Abstract][Full Text] [Related]
9. Thromboembolic complications after mitral valve replacement with Hancock xenograft.
Hetzer R; Hill JD; Kerth WJ; Ansbro J; Adappa MG; Rodvien R; Kamm B; Gerbode F
J Thorac Cardiovasc Surg; 1978 May; 75(5):651-8. PubMed ID: 565444
[TBL] [Abstract][Full Text] [Related]
10. Impact of left atrial size reduction on chronic atrial fibrillation in mitral valve surgery.
Scherer M; Dzemali O; Aybek T; Wimmer-Greinecker G; Moritz A
J Heart Valve Dis; 2003 Jul; 12(4):469-74. PubMed ID: 12918849
[TBL] [Abstract][Full Text] [Related]
11. Left atrial appendage obliteration in atrial fibrillation patients undergoing bioprosthetic mitral valve replacement.
Min XP; Zhu TY; Han J; Li Y; Meng X
Herz; 2016 Feb; 41(1):87-94. PubMed ID: 26341228
[TBL] [Abstract][Full Text] [Related]
12. Variation in warfarin thromboprophylaxis after mitral valve repair: does equipoise exist and is a randomized trial warranted?
Suri RM; Thourani VH; He X; Brennan JM; O'Brien SM; Rankin JS; Schaff HV; Gammie JS
Ann Thorac Surg; 2013 Jun; 95(6):1991-8; discussion 1998-9. PubMed ID: 23706423
[TBL] [Abstract][Full Text] [Related]
13. Mid-term results after Epic xenograft implantation for aortic, mitral, and double valve replacement.
Lehmann S; Walther T; Leontjev S; Kempfert J; Rastan A; Garbade J; Borger MA; Falk V; Mohr FW
J Heart Valve Dis; 2007 Nov; 16(6):641-8; discussion 648. PubMed ID: 18095514
[TBL] [Abstract][Full Text] [Related]
14. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Douketis JD; Johnson JA; Turpie AG
Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
[TBL] [Abstract][Full Text] [Related]
15. Cryoablation for surgical treatment of chronic atrial fibrillation combined with mitral valve surgery: a clinical observation.
Ghavidel AA; Javadpour H; Shafiee M; Tabatabaie MB; Raiesi K; Hosseini S
Eur J Cardiothorac Surg; 2008 Jun; 33(6):1043-8. PubMed ID: 18448351
[TBL] [Abstract][Full Text] [Related]
16. Risk-benefit analysis of warfarin therapy in Hancock mitral valve replacement.
Hill JD; LaFollette L; Szarnicki RJ; Avery GJ; Wilson RM; Gerbode F; Kerth WJ; Rodvien R
J Thorac Cardiovasc Surg; 1982 May; 83(5):718-23. PubMed ID: 6978975
[TBL] [Abstract][Full Text] [Related]
17. The long-term risk of warfarin sodium therapy and the incidence of thromboembolism in children after prosthetic cardiac valve replacement.
Stewart S; Cianciotta D; Alexson C; Manning J
J Thorac Cardiovasc Surg; 1987 Apr; 93(4):551-4. PubMed ID: 3561002
[TBL] [Abstract][Full Text] [Related]
18. Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review.
Carrel TP; Klingenmann W; Mohacsi PJ; Berdat P; Althaus U
J Heart Valve Dis; 1999 Jul; 8(4):392-8. PubMed ID: 10461238
[TBL] [Abstract][Full Text] [Related]
19. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.
Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W
Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852
[TBL] [Abstract][Full Text] [Related]
20. Seven-year results with the St Jude Medical Silzone mechanical prosthesis.
Jamieson WR; Fradet GJ; Abel JG; Janusz MT; Lichtenstein SV; MacNab JS; Stanford EA; Chan F
J Thorac Cardiovasc Surg; 2009 May; 137(5):1109-15.e2. PubMed ID: 19379975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
